Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-02

Clinical Trial Update: Optic Neuritis Recovery After Oral or IV Corticosteroids [Phase 2, Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 2/3 trial examining recovery from optic neuritis after oral or intravenous corticosteroid therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPREDNISOLONE (methylprednisolone)
  • PREDNISONE (Prednisone)

Snippet

Sponsor: London Health Sciences Centre | Conditions: Optic Neuritis | Phase 2, Phase 3 | Status: COMPLETED